Experiences and lessons learned by genetic counselors in returning secondary genetic findings to patients
Authors:
- 26 May 2020
- journal article
- research article
- Published by Wiley in Journal of Genetic Counseling
- Vol. 29 (6) , 1234-1244
Abstract
Few studies have explored the real‐world experiences and strategies of genetic counselors involved in the process of returning secondary findings (SFs). This study aimed to describe and categorize the experiences for the return of SFs from clinical sequencing. Semi‐structured telephone interviews with 21 genetic counselors representing 56 incidences were conducted. A content analysis was conducted on the transcripts through an iterative, team‐based approach. Four common categories emerged across all interviews. These included (a) the importance of pretest counseling for the return of SFs, (b) how primary test results influenced the level of importance placed on the SFs, (c) patients' emotional reactions from receiving SF results, and (d) how returning SFs changed future pretest counseling and consent. This study identified experiences and common practices by genetic counselors who returned SFs. More research is needed to assess how genetic counselors' specific strategies improve patient comprehension and medical actions.Keywords
Funding Information
- University of Utah Graduate Program in Genetic Counseling
- Utah Center for Excellence in ELSI Research
- National Human Genome Research Institute of the National Institutes of Health (RM1HG009037)
This publication has 33 references indexed in Scilit:
- Paternalism and the ACMG recommendations on genomic incidental findings: patients seen but not heardGenetics in Medicine, 2013
- Genetics specialists’ perspectives on disclosure of genomic incidental findings in the clinical settingPatient Education and Counseling, 2013
- “Grasping the Grey”: Patient Understanding and Interpretation of an Intermediate Allele Predictive Test Result for Huntington DiseaseJournal of Genetic Counseling, 2012
- “I want to know what's in Pandora's box”: Comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencingAmerican Journal of Medical Genetics Part A, 2012
- Informed consent for whole genome sequencing: A qualitative analysis of participant expectations and perceptions of risks, benefits, and harmsAmerican Journal of Medical Genetics Part A, 2012
- The legal risks of returning results of genomics researchGenetics in Medicine, 2012
- Exploring Challenges to Telehealth Communication by Specialists in Poison InformationQualitative Health Research, 2011
- A formal risk-benefit framework for genomic tests: Facilitating the appropriate translation of genomics into clinical practiceGenetics in Medicine, 2010
- Reconsidering the Role of Interaction in Analyzing and Reporting Focus GroupsQualitative Health Research, 2010
- Whatever happened to qualitative description?Research in Nursing & Health, 2000